Urology

Articles

• 2018. Peters ML et al. – Dutch economic value of Radium-223 in metastatic castration-resistant prostate cancer
• 2017. Kauf TL et al. – Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections
• 2017. Long JA et al. – [Robot assisted radical prostatectomy: What are the evidence at the time of a specific funding?
• 2012. Matlaga BR et al. – Economic outcomes of treatment for ureteral and renal stones: A systematic literature review
• 2012. Matlaga BR et al. – Treatment of ureteral and renal stones: A systematic review and meta-analysis of randomized, controlled trials
• 2012. Piault E et al. – Linguistic validation of translation of the Self-Assessment Goal Achievement (SAGA) questionnaire from English
• 2012. Humphrey L et al. – The bladder pain/interstitial cystitis symptom score: Development, validation, and identification of a cut score
• 2009. Chevret-Meason M et al. – The Index of Sexual Life questionnaire: A unique and valid tool to evaluate sexual quality of life and satisfaction of female partners of men with erectile dysfunction
• 2009. Chevret-Méasson M et al. – Improvement in quality of sexual life in female partners of men with erectile dysfunction treated with sildenafil citrate: Findings of the Index of Sexual Life (ISL) in a couple study
• 2008. Haab F et al. – Comprehensive evaluation of bladder and urethral dysfunction symptoms: Development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire
• 2006. Acquadro C et al. – Translating overactive bladder questionnaires in 14 languages

Posters & Presentations

• 2017. ISPOR European Congress – Estimating utilities/disutilities for high risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events
• 2015. ISPOR European Congress – Results of a Dutch Cost-Effectiveness Model of Radium-223 in Comparison to Cabazitaxel, Abiraterone, and Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer Previously Treated with Docetaxel
• 2012. ISPOR European Congress – Development of a Patient Adherence Specific Scale for Use in the Management of Benign Prostatic Hyperplasia Patients
• 2010. ISPOR European Congress – Confirmation of Brief Pain Inventory Short Form (BPI-SF) ‘Worst Pain’ Item Cut-Point for the Assessment of Pain Progression in Castration-Resistant Prostate Cancer (CRPC)
• 2009. ISPOR European Congress – How Do Patients Describe Their Symptoms of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)? Qualitative Interviews with Patients to Support the Development of a Patient-Reported Symptom-Based Screener for IC/PBS
• 2006. ISPOR European Congress – Risk of Leakages in Daily Activities, Re-Working the Conceptual Framework
• 2006. ISPOR European Congress – Linguistic Validation of the Overactive Bladder Satisfaction Questionnaire (OAB-S) in 13 Languages
• 2006. ISPOR European Congress – Comparison of the PRO Endpoints Found in Labeling Claims of Urinary Incontinence Drugs with Those Recommended by the Corresponding EMEA Note for Guidance
• 2005. ISPOR European Congress – Patient Satisfaction: Psychometric Validation of the OAB-S, an Overactive Bladder Treatment Satisfaction Questionnaire
• 2005. ISPOR European Congress – Development and Testing of a Composite Scale to Assess Therapeutic Response in Stress Urinary Incontinence
• 2005. ISPOR European Congress – Development and Pilot Testing of a New Scale Specifically Measuring the Impact of Stress Urinary Incontinence (SUI) on Common Physical Activities of Daily Life
• 2005. ISPOR European Congress – Development and Validation of a Comprehensive Symptom Checklist in Urinary Incontinence
• 2005. ISPOR European Congress – Patient Satisfaction: International Development, Translatability Assessment and Linguistic Validation of the OAB-S, an Overactive Bladder Treatment Satisfaction Questionnaire
• 1999. ISPOR Annual International Meeting – Linguistic Validation of the King’s Health Questionnaire (KHQ) in 8 Languages
• 1999. ISPOR Annual International Meeting – Linguistic Validation of the Urinary Incontinence Questionnaire
• 1999. ISPOR Annual International Meeting – Development and Psychometric Validation of a Quality of Life Questionnaire in Urinary Incontinence (CONTILIFE®).